4576-90-3

Basic information

• Product Name: 3-Isothiazolecarboxylic acid
• Synonyms: isothiazole-3-carboxylic acid;3-ISOTHIAZOLE CARBOXYLIC ACID;3-Carboxyisothiazole;Isothiazole-3-carboxylic acid 97%;1,2-thiazole-3-carboxylic acid;3-Carboxyisothiazole, 1,2-Thiazole-3-carboxylic acid;Isothiazole-3-carboxylicacid97%
• CAS NO: 4576-90-3
• Molecular Formula: C₄H₃NO₂S
• Molecular Weight: 129.14
• Mol File: 4576-90-3.mol

Chemical Properties

• Boiling Point: 178 °C
• Flash Point: 62 °C
• Appearance: /
• Density: 1.525
• Vapor Pressure: 0.65mmHg at 25°C
• Refractive Index: 1.617
• Storage Temp.: 2-8°C
• PKA: 1.08±0.10(Predicted)
• CAS DataBase Reference: 3-Isothiazolecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Isothiazolecarboxylic acid(4576-90-3)
• EPA Substance Registry System: 3-Isothiazolecarboxylic acid(4576-90-3)

Safety Data

• Hazardous Substances Data: 4576-90-3(Hazardous Substances Data)

Usage

Uses

3-Isothiazolecarboxylic acid

InChI:InChI=1/C4H3NO2S/c6-4(7)3-1-2-8-5-3/h1-2H,(H,6,7)

Upstream product

• 4576-91-4 3-bromomethylisothiazole 
• 693-92-5 3-methylisothiazole 

Downstream Products

• 1026765-94-5 C₁₅H₁₅N₃O₂S 
• 72592-18-8 tert-butyl isothiazol-3-ylcarbamate 

Relevant articles and documents

CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME

The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.

(1,4-DIAZA-BICYCLO[3.2.2]NON-6-EN-4-YL)-HETEROCYCLYL-METHANONE LIGANDS FOR NICOTINIC ACETYLCHOLINE RECEPTORS, USEFUL FOR THE TREATMENT OF DISEASE

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds, which act as ligands for the a7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof. The novel compounds include compounds of formula I: (I) wherein X, R1, and R2 are as herein defined.

3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels

3-Phenyl (or meta or para-substituted phenyl)-4-permissibly substituted-5-isothiazolecarboxylic acids, salts, esters and simple amides, used to lower uric acid levels in mammals.